Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4HTR3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 212 | 216 | PF00656 | 0.678 |
CLV_C14_Caspase3-7 | 231 | 235 | PF00656 | 0.602 |
CLV_PCSK_SKI1_1 | 175 | 179 | PF00082 | 0.459 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.546 |
CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.519 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.486 |
DEG_ODPH_VHL_1 | 12 | 24 | PF01847 | 0.484 |
DOC_USP7_MATH_1 | 104 | 108 | PF00917 | 0.755 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.729 |
DOC_USP7_UBL2_3 | 96 | 100 | PF12436 | 0.751 |
DOC_WW_Pin1_4 | 150 | 155 | PF00397 | 0.760 |
DOC_WW_Pin1_4 | 63 | 68 | PF00397 | 0.731 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.736 |
LIG_14-3-3_CanoR_1 | 47 | 57 | PF00244 | 0.701 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.788 |
LIG_FHA_2 | 112 | 118 | PF00498 | 0.650 |
LIG_LIR_Gen_1 | 16 | 27 | PF02991 | 0.361 |
LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 16 | 22 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.493 |
LIG_SH2_CRK | 17 | 21 | PF00017 | 0.331 |
LIG_SH2_PTP2 | 19 | 22 | PF00017 | 0.325 |
LIG_SH2_SRC | 17 | 20 | PF00017 | 0.452 |
LIG_SH2_STAP1 | 17 | 21 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.514 |
LIG_SH3_3 | 151 | 157 | PF00018 | 0.826 |
LIG_SH3_3 | 3 | 9 | PF00018 | 0.535 |
LIG_SH3_3 | 51 | 57 | PF00018 | 0.738 |
LIG_TRAF2_1 | 143 | 146 | PF00917 | 0.778 |
MOD_CDK_SPxK_1 | 150 | 156 | PF00069 | 0.788 |
MOD_CDK_SPxxK_3 | 63 | 70 | PF00069 | 0.734 |
MOD_CK1_1 | 188 | 194 | PF00069 | 0.768 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.742 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.793 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.501 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.545 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.482 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.550 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.478 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.804 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.746 |
MOD_N-GLC_1 | 150 | 155 | PF02516 | 0.612 |
MOD_N-GLC_1 | 202 | 207 | PF02516 | 0.506 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.725 |
MOD_NEK2_1 | 228 | 233 | PF00069 | 0.661 |
MOD_PIKK_1 | 155 | 161 | PF00454 | 0.763 |
MOD_Plk_1 | 111 | 117 | PF00069 | 0.649 |
MOD_ProDKin_1 | 150 | 156 | PF00069 | 0.762 |
MOD_ProDKin_1 | 63 | 69 | PF00069 | 0.732 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.738 |
TRG_DiLeu_BaEn_1 | 219 | 224 | PF01217 | 0.722 |
TRG_DiLeu_BaEn_4 | 219 | 225 | PF01217 | 0.721 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.507 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HR49 | Leptomonas seymouri | 43% | 100% |
A0A3Q8IE41 | Leishmania donovani | 95% | 98% |
A4H9A5 | Leishmania braziliensis | 62% | 100% |
A4HXM5 | Leishmania infantum | 95% | 98% |
C9ZUK7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9ARC1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
Q4QBZ4 | Leishmania major | 85% | 100% |
Q4QE42 | Leishmania major | 85% | 100% |